Key financial figures from InteliCare's quarterly report

InteliCare Holdings (ASX:ICR) released its quarterly cash flow report for the period ending 30 September 2024. The company reported a net cash decrease of $685,000 from operating activities. However, it saw positive cash inflows from financing activities, with net proceeds of $1,397,000. This resulted in an increase in cash and cash equivalents to $1,546,000 by the end of the quarter.

Overview and future outlook for InteliCare Holdings

InteliCare Holdings (ASX:ICR) reported a net decrease in cash from its operating activities, amounting to $685,000 for the quarter ending September 2024. The company had significant cash inflows from financing activities, primarily from equity issuance, which added $1,397,000 to its finances. As a result, InteliCare increased its cash position from $834,000 to $1,546,000. The company also noted that its available cash could cover approximately 2.26 quarters of operating expenses at the current rate. No cash flows were recorded from investing activities, and related party transactions totaled $63,000. A funding facility secured against the FY24 R&D estimated claim, amounting to $503,000, was also highlighted. This report underscores InteliCare's reliance on financing to support its operations and management of cash flow.

Executive insights on InteliCare's financial status

The cash flow report was authorized for release by the Board of InteliCare Holdings Limited on 31 October 2024.